openPR Logo
Press release

Intranasal Drug Delivery Applications Market - Global Industry Analysis, Emerging Trends and New Technologies Research upto 2019

09-26-2016 08:54 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Intranasal Drug Delivery Applications Market - Global Industry

Intranasal drug delivery systems administer drugs through nasal route for local or systemic action based on the desired therapeutic modality to the patients. Nasals drugs may be prescribed for acute or chronic treatments and include antibiotics, snuffs, vasoconstrictors, local anesthetics, pain relief drugs, calcium supplements and antihistamines and others. Such drugs are administered in several dosage forms like nasal sprays, ointments and solutions. Drug candidates with poor oral absorption and exposed to first-pass effect in the body are preferred in formulation of nasal drug delivery.

Brochure Download: http://bit.ly/2dsHIE0

The global intranasal drug delivery market is categorized by its therapeutic applications:

-Allergic infections
-Analgesic
-Osteoporosis
-Pain management
-Sexual dysfunction
-Vaccines

Globally, North America is the largest market for intranasal drug delivery application and is followed by Europe and Asia-Pacific. Developing countries of Asia, Middle East and Latin America are expected to witness maximum market growth due to development of economy, improved healthcare infrastructure, escalating penetration of medical insurances and growing incidences of chronic diseases.

Patent expiration of blockbuster drugs, high prevalence of cardiovascular diseases, cancer and diabetes, adoption of self administration practices, rising demand for home healthcare devices and increased focus on pediatric and elderly patients are some of the major factors impelling the market growth of intranasal drug delivery systems across the globe.

Other factors driving this market include rapid research and development and adoption of new drug delivery technologies and devices, fast onset of action and reformulation of oral drugs and injections into the formulations to be administered by nasal route. However, drug formulation failure and market recalls, and technical barrier may pose a challenge to the growth of this market.

Browse Research Report: http://bit.ly/2cvy1mh

Aegis Therapeutics LLC, Alza Corporation, AstraZeneca PLC., MedImmune, Inc., Baxter International, Inc., Becton, Dickinson and Company, GlaxoSmithKline PLC, Johnson & Johnson, Inc., Marina Biotech, Inc., Merck & Co., Novartis AG, Pfizer Inc., Valeant Pharmaceuticals International, Inc. and Rexam PLC are some of the major players contributing to the global intranasal drug delivery applications market.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intranasal Drug Delivery Applications Market - Global Industry Analysis, Emerging Trends and New Technologies Research upto 2019 here

News-ID: 366764 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Intranasal

Emerging Trends Influencing The Growth Of The Intranasal Drug Delivery Devices M …
"The Intranasal Drug Delivery Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Intranasal Drug Delivery Devices Market Size Expected to Be by 2034? Over recent years, the intranasal drug delivery devices market has seen strong growth. An expansion from $60.27 billion
Market Mastery: Intranasal Drug Delivery Devices Market Impact Beyond Expectatio …
The Intranasal Drug Delivery Devices Market 𝐑𝐞𝐩𝐨𝐫𝐭 dissects the complex fragments of the Market in an easy-to-read manner. This report covers drivers, restraints, challenges, and threats in the Intranasal Drug Delivery Devices Market to understand the overall scope of the Market in a detailed yet concise manner. Additionally, the Market report covers the top-winning strategies implemented by major industry players and technological advancements that steer the growth of the Market. 𝐂𝐥𝐚𝐢𝐦
Intranasal Corticosteroids Market 2021 | Detailed Report
ReportsnReports publishes the report titled Intranasal Corticosteroids that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,
Intranasal Drug Delivery Devices Market to Witness Robust Expansion by 2025
Market Research Report Store offers a latest published report on Intranasal Drug Delivery Devices Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Intranasal Drug Delivery Devices market will register a 10.8% CAGR in terms of revenue, the global market size will reach US$ 1269.8 million by 2024, from US$ 842.9
Intranasal Corticosteroids Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Intranasal Corticosteroids Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Intranasal Corticosteroids market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,
Intranasal Drug Delivery Market to Reflect Impressive Expansion During 2015-2021
Drug delivery refers to a process of delivering a drug into the patient’s body to have an effective therapeutic effect. Different modes are used for the delivery of drug. Nasal and pulmonary routes are most popular modes for delivering drug. The global drug delivery market is growing at a significant rate due to growing awareness in the field and technical innovations in the field. Intranasal drug delivery refers to a